LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 258 of 520
Next
>>
>
6426 to 6450 of 12982 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	CP724714	3.33	uM	LJP5	2	A08	72	hr	1334	3247	4051	0.8015	0.7420
BT-20	CP724714	3.33	uM	LJP5	3	A08	72	hr	1334	3776	4117	0.9170	0.8962
BT-20	CP724714	10	uM	LJP5	1	A07	72	hr	1334	2474	3930	0.6294	0.4859
BT-20	CP724714	10	uM	LJP5	2	A07	72	hr	1334	2407	4051	0.5942	0.4450
BT-20	CP724714	10	uM	LJP5	3	A07	72	hr	1334	3149	4117	0.7648	0.6958
BT-20	Alvocidib	0.04	uM	LJP6	1	A18	72	hr	1334	2422	3955	0.6123	0.4625
BT-20	Alvocidib	0.04	uM	LJP6	2	A18	72	hr	1334	3088	3899	0.7920	0.7200
BT-20	Alvocidib	0.04	uM	LJP6	3	A18	72	hr	1334	3014	3921	0.7686	0.6886
BT-20	Alvocidib	0.12	uM	LJP6	1	A17	72	hr	1334	1606	3955	0.4060	0.1253
BT-20	Alvocidib	0.12	uM	LJP6	2	A17	72	hr	1334	1608	3899	0.4124	0.1280
BT-20	Alvocidib	0.12	uM	LJP6	3	A17	72	hr	1334	1537	3921	0.3920	0.0950
BT-20	Alvocidib	0.37	uM	LJP6	1	A16	72	hr	1334	764	3955	0.1931	-0.2995
BT-20	Alvocidib	0.37	uM	LJP6	2	A16	72	hr	1334	774	3899	0.1985	-0.2969
BT-20	Alvocidib	0.37	uM	LJP6	3	A16	72	hr	1334	700	3921	0.1785	-0.3397
BT-20	Alvocidib	1.11	uM	LJP6	1	A15	72	hr	1334	383	3955	0.0968	-0.5491
BT-20	Alvocidib	1.11	uM	LJP6	2	A15	72	hr	1334	359	3899	0.0921	-0.5722
BT-20	Alvocidib	1.11	uM	LJP6	3	A15	72	hr	1334	368	3921	0.0938	-0.5633
BT-20	Alvocidib	3.33	uM	LJP6	1	A14	72	hr	1334	405	3955	0.1024	-0.5327
BT-20	Alvocidib	3.33	uM	LJP6	2	A14	72	hr	1334	369	3899	0.0946	-0.5645
BT-20	Alvocidib	3.33	uM	LJP6	3	A14	72	hr	1334	319	3921	0.0813	-0.6017
BT-20	Alvocidib	10	uM	LJP6	1	A13	72	hr	1334	359	3955	0.0908	-0.5673
BT-20	Alvocidib	10	uM	LJP6	2	A13	72	hr	1334	290	3899	0.0744	-0.6273
BT-20	Alvocidib	10	uM	LJP6	3	A13	72	hr	1334	302	3921	0.0770	-0.6155
BT-20	GW843682X	0.04	uM	LJP6	1	B18	72	hr	1334	3523	3955	0.8906	0.8575
BT-20	GW843682X	0.04	uM	LJP6	2	B18	72	hr	1334	3785	3899	0.9707	0.9620

|<
<<
Previous
Page 258 of 520
Next
>>
>
6426 to 6450 of 12982 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)